Improved survival after cytoreductive nephrectomy for metastatic renal cell carcinoma in the contemporary immunotherapy era: An analysis of the National Cancer Database

OBJECTIVES: Despite immune checkpoint inhibitor (ICI) approval for metastatic renal cell carcinoma (mRCC) in 2015, cytoreductive nephrectomy (CN) is guided by extrapolation from earlier classes of therapy. We evaluated survival outcomes, timing, and safety of combining CN with modern immunotherapy (...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Urol Oncol
Main Authors: Singla, Nirmish, Hutchinson, Ryan C., Ghandour, Rashed A., Freifeld, Yuval, Fang, Dong, Sagalowsky, Arthur I., Lotan, Yair, Bagrodia, Aditya, Margulis, Vitaly, Hammers, Hans J., Woldu, Solomon L.
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7269798/
https://ncbi.nlm.nih.gov/pubmed/32253116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2020.02.029
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki